What is the Evidence Supporting IVIG Use in Neonates?
Numerous studies and clinical trials support the use of IVIG in neonatal disorders. For instance, randomized controlled trials have demonstrated the efficacy of IVIG in reducing the need for exchange transfusions in HDN and increasing platelet counts in neonatal ITP. Additionally, meta-analyses have shown that IVIG can improve outcomes in neonatal sepsis when used as adjunctive therapy.
